We used small molecule inhibitors of FOXM1 to understand how they impact gene regulatory networks in suppressing cancer cell survival and the rewiring of gene networks that occurs when breast cancer cells become resistant to these compounds. This evidence concerns the gene FOXM1 and breast cancer.